Kayne Anderson Rudnick Investment Management
IDXX icon

Kayne Anderson Rudnick Investment Management’s Idexx Laboratories IDXX Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7M Sell
83,104
-17,736
-18% -$9.95M 0.14% 128
2026
Q1 		$56.7M Sell
100,840
-12,267
-11% -$7.87M 0.17% 120
2025
Q4 		$76.5M Sell
113,107
-17,092
-13% -$11.6M 0.21% 111
2025
Q3 		$83.2M Buy
130,199
+19,183
+17% +$11.6M 0.2% 113
2025
Q2 		$59.5M Sell
111,016
-8,171
-7% -$3.91M 0.14% 123
2025
Q1 		$50.1M Sell
119,187
-10,715
-8% -$4.65M 0.12% 135
2024
Q4 		$53.7M Sell
129,902
-6,695
-5% -$2.94M 0.12% 133
2024
Q3 		$69M Sell
136,597
-4,009
-3% -$1.95M 0.15% 122
2024
Q2 		$68.5M Sell
140,606
-6,194
-4% -$3.11M 0.17% 120
2024
Q1 		$79.3M Sell
146,800
-3,369
-2% -$1.84M 0.18% 118
2023
Q4 		$83.4M Buy
150,169
+683
+0.5% +$321K 0.21% 113
2023
Q3 		$65.4M Sell
149,486
-7,284
-5% -$3.63M 0.19% 121
2023
Q2 		$78.7M Sell
156,770
-2,209
-1% -$1.06M 0.22% 113
2023
Q1 		$79.5M Sell
158,979
-2,984
-2% -$1.43M 0.23% 114
2022
Q4 		$66.1M Buy
161,963
+52,784
+48% +$20.5M 0.21% 120
2022
Q3 		$35.6M Buy
109,179
+12,575
+13% +$4.62M 0.12% 139
2022
Q2 		$33.9M Buy
96,604
+2,370
+3% +$966K 0.11% 148
2022
Q1 		$51.6M Sell
94,234
-2,717
-3% -$1.43M 0.14% 140
2021
Q4 		$63.8M Buy
96,951
+422
+0.4% +$265K 0.15% 138
2021
Q3 		$60M Buy
96,529
+591
+0.6% +$397K 0.15% 138
2021
Q2 		$60.6M Buy
95,938
+204
+0.2% +$113K 0.15% 140
2021
Q1 		$46.8M Buy
95,734
+2,261
+2% +$1.13M 0.13% 145
2020
Q4 		$46.7M Buy
93,473
+7,034
+8% +$3.15M 0.14% 138
2020
Q3 		$34M Buy
86,439
+18,233
+27% +$6.74M 0.12% 145
2020
Q2 		$22.5M Buy
68,206
+22,921
+51% +$6.64M 0.09% 155
2020
Q1 		$11M Buy
45,285
+45,280
+905,600% +$11.8M 0.06% 165
2019
Q4 		$1K Buy
+5
New +$1.32K ﹤0.01% 619

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's IDXX Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $9.95M and leaving 83,104 shares worth $43.7M. The position accounts for 0.14% of the portfolio, ranked #128.

Kayne Anderson Rudnick Investment Management first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $83.4M in Q4 2023. 1,294 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 83,104 shares of Idexx Laboratories worth $43.7M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 17,736 Idexx Laboratories shares in Q2 2026, an estimated $9.95M.
  • Idexx Laboratories made up 0.14% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #128 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Kayne Anderson Rudnick Investment Management's Idexx Laboratories position peaked at $83.4M in Q4 2023.
  • 1,294 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.